Welcome to our dedicated page for NeueHealth news (Ticker: $NEUE), a resource for investors and traders seeking the latest updates and insights on NeueHealth stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NeueHealth's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NeueHealth's position in the market.
NeueHealth, Inc. reported strong Q1 '24 results with Revenue of $245.1 million, Net Income of $5.7 million, and Adjusted EBITDA of $2.5 million. They focus on consumer-centric care, provider partnerships, and consumer engagement. Revenue guidance for 2024 is around $1 billion, with expected segment revenues of $310-320 million for NeueCare and $690-700 million for NeueSolutions. The company aims for an Adjusted EBITDA of $15-25 million in 2024.